In the BioHarmony Drug Report Database
Dacarbazine
Dtic-dome (dacarbazine) is a small molecule pharmaceutical. Dacarbazine was first approved as Dtic-dome on 1982-01-01. It is used to treat fibrosarcoma, hodgkin disease, islet cell carcinoma, medullary carcinoma, and melanoma amongst others in the USA.
Trade Name
|
Dtic-dome |
|---|---|
Common Name
|
dacarbazine |
ChEMBL ID
|
CHEMBL476 |
Indication
|
fibrosarcoma, hodgkin disease, islet cell carcinoma, medullary carcinoma, melanoma, neuroblastoma, rhabdomyosarcoma |
Drug Class
|
Image (chem structure or protein)